Get my own profile
Public access
View all36 articles
7 articles
available
not available
Based on funding mandates
Co-authors
Mikhail SavitskiEMBLVerified email at embl.de
Gerard DrewesCellzome/GlaxoSmithKline R&DVerified email at gsk.com
Bernhard KusterTechnical University of MunichVerified email at tum.de
Isabelle BecherEMBL HeidelbergVerified email at embl.de
Nico ZinnCellzome GmbH, a GSK companyVerified email at gsk.com
Wolfgang HuberEMBL - European Molecular Biology LaboratoryVerified email at embl.org
Nils KurzawaCellzome, a GSK companyVerified email at gsk.com
Friedrich ReinhardVP Academic Partnerships, Evotec International GmbHVerified email at evotec.com
Michael O. GlockerProteome Center RostockVerified email at med.uni-rostock.de
Mathias WilhelmComputational Mass Spectrometry, Technical University of MunichVerified email at tum.de
Hannes HahneOmicScouts GmbHVerified email at omicscouts.com
Markus SchirleNovartis Biomedical ResearchVerified email at novartis.com
Rab PrinjhaChief R&D Officer Curve TherapeuticsVerified email at Curvetx.com
Yann AbrahamJohnson & JohnsonVerified email at its.jnj.com
Hans-Juergen ThiesenProfessor of Immunology,University RostockVerified email at med.uni-rostock.de
Dominic HelmProteomics Core Facility, DKFZVerified email at dkfz-heidelberg.de
Par NordlundKarolinska InstitutetVerified email at ki.se
Daniel Martinez MolinaCSO at Pelago Bioscience, SwedenVerified email at pelagobio.com
Fiona PachlAstraZenecaVerified email at astrazeneca.com
Arjen ScholtenPrincipal Scientist Analytical Development; Janssen Vaccines & PreventionVerified email at its.jnj.com